Phase I clinical study with multiple peptide vaccines in combination with tetanus toxoid and GM-CSF in advanced-stage HLA-A* 0201-positive melanoma patients
A Bins, H Mallo, J Sein, C van den Bogaard… - Journal of …, 2007 - journals.lww.com
Successful induction of functional tumor-specific T cells by peptide vaccination in animal
models has resulted in many clinical trials to test this approach in advanced-stage …
models has resulted in many clinical trials to test this approach in advanced-stage …
Phase I clinical study with multiple peptide vaccines in combination with tetanus toxoid and GM-CSF in advanced-stage HLA-A* 0201-positive melanoma patients
A Bins, H Mallo, J Sein… - Journal of …, 2007 - researchinformation.amsterdamumc …
Successful induction of functional tumor-specific T cells by peptide vaccination in animal
models has resulted in many clinical trials to test this approach in advanced-stage …
models has resulted in many clinical trials to test this approach in advanced-stage …
Phase I clinical study with multiple peptide vaccines in combination with tetanus toxoid and GM-CSF in advanced-stage HLA-A* 0201-positive melanoma patients.
A Bins, H Mallo, J Sein, C van den Bogaard… - Journal of …, 2007 - europepmc.org
Successful induction of functional tumor-specific T cells by peptide vaccination in animal
models has resulted in many clinical trials to test this approach in advanced-stage …
models has resulted in many clinical trials to test this approach in advanced-stage …
Phase I Clinical Study With Multiple Peptide Vaccines in Combination With Tetanus Toxoid and GM-CSF in Advanced-stage HLA-A* 0201-positive Melanoma Patients
A Bins, H Mallo, J Sein, C van den Bogaard… - Journal of …, 2007 - journals.lww.com
Successful induction of functional tumor-specific T cells by peptide vaccination in animal
models has resulted in many clinical trials to test this approach in advanced-stage …
models has resulted in many clinical trials to test this approach in advanced-stage …
[引用][C] Phase I Clinical Study With Multiple Peptide Vaccines in Combination With Tetanus Toxoid and GM-CSF in Advanced-stage HLA-A* 0201-positive Melanoma …
A Bins, H Mallo, J Sein, C van den Bogaard… - Journal of …, 2007 - cir.nii.ac.jp
Phase I Clinical Study With Multiple Peptide Vaccines in Combination With Tetanus Toxoid and
GM-CSF in Advanced-stage HLA-A*0201-positive Melanoma Patients | CiNii Research CiNii …
GM-CSF in Advanced-stage HLA-A*0201-positive Melanoma Patients | CiNii Research CiNii …
[PDF][PDF] Phase I clinical study with multiple peptide vaccines in combination with tetanus toxoid and GM CSF in advanced stage HLA A 0201 positive melanoma patients …
A Bins, H Mallo, J Sein, FV Dreese, B Nuijen, G de Gast… - scholarlypublications …
Successful induction of functional tumor specific T cells by peptide vaccination in animal
models has resulted in many clinical trials to test this approach in advancedY stage …
models has resulted in many clinical trials to test this approach in advancedY stage …
[引用][C] Phase I clinical study with multiple peptide vaccines in combination with tetanus toxoid and GM-CSF in advanced-stage HLA-A* 0201-positive melanoma …
A BINS, H MALLO, J SEIN… - Journal of …, 2007 - pascal-francis.inist.fr
Phase I clinical study with multiple peptide vaccines in combination with tetanus toxoid and
GM-CSF in advanced-stage HLA-A*0201-positive melanoma patients CNRS Inist Pascal-Francis …
GM-CSF in advanced-stage HLA-A*0201-positive melanoma patients CNRS Inist Pascal-Francis …
Phase I clinical study with multiple peptide vaccines in combination with tetanus toxoid and GM-CSF in advanced-stage HLA-A* 0201-positive melanoma patients
A Bins, H Mallo, J Sein… - Journal of …, 2007 - pubmed.ncbi.nlm.nih.gov
Successful induction of functional tumor-specific T cells by peptide vaccination in animal
models has resulted in many clinical trials to test this approach in advanced-stage …
models has resulted in many clinical trials to test this approach in advanced-stage …
[引用][C] Phase I clinical study with multiple peptide vaccines in combination with tetanus toxoid and GM-CSF in advanced-stage HLA-A^* 0201-positive melanoma …
A BINS - J Immunother, 2007 - cir.nii.ac.jp
Phase I clinical study with multiple peptide vaccines in combination with tetanus toxoid and
GM-CSF in advanced-stage HLA-A^*0201-positive melanoma patients | CiNii Research …
GM-CSF in advanced-stage HLA-A^*0201-positive melanoma patients | CiNii Research …